Skip to menu Skip to content Skip to footer

2024

Other Outputs

Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment

Wang, Yufan (2024). Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment. PhD Thesis, School of Nursing, Midwifery and Social Work, The University of Queensland. doi: 10.14264/23460ca

Assessing the value for money of integrating exercise as therapy after gynaecological cancer treatment

2023

Conference Publication

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2023). Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer. HTAi 2023 Meeting, Adelaide, SA Australia, 24-28 June 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0266462323001277

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

2023

Journal Article

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

Wang, Yufan, McCarthy, Alexandra L., Hayes, Sandra C., Gordon, Louisa G., Chiu, Vivian, Bailey, Tom G., Stewart, Elizabeth and Tuffaha, Haitham (2023). Economic evaluation of exercise interventions for individuals with cancer: a systematic review. Preventive Medicine, 172 107491, 1-8. doi: 10.1016/j.ypmed.2023.107491

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

2023

Journal Article

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Wang, Yufan, McCarthy, Alexandra L and Tuffaha, Haitham (2023). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. Supportive Care in Cancer, 31 (7) 391, 391. doi: 10.1007/s00520-023-07819-y

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

2022

Conference Publication

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Wang, Yufan, McCarthy, Alexandra and Tuffaha, Haitham (2022). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

2024

Conference Publication

Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework

Wang, Yufan, McCarthy, Sandie and Tuffaha, Haitham (2024). Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework

2024

Journal Article

Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model

Li, Jianrong, Li, Chu, Li, Xiaolian, Chen, Yuling, Li, Zhangfu, Lin, Yuntao, Jing, Huan, Wang, Yufan and Yang, Hongyu (2024). Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model. Journal of Cancer, 15 (18), 6022-6037. doi: 10.7150/jca.98350

Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model